chr22-36763972-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_001177701.3(IFT27):c.299G>A(p.Cys100Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000186 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001177701.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 19 Pathogenic:2
Variant summary: IFT27 c.296G>A (p.Cys99Tyr) results in a non-conservative amino acid change located in the Small GTP-binding protein domain (IPR005225) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251490 control chromosomes. c.296G>A has been reported in the literature as a biallelic homozygous genotype in at-least two individuals from one consanguineous family affected with Bardet-Biedl Syndrome 19 (example, Aldamesh_2014 cited by Shaheen_2016, Zhou_2022, Schaefer_2019). It has also been observed as a homozygous occurrence in an internal case affected with features of Bardet-Biedl Syndrome. These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24488770, 30761183, 27894351, 34888642). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
IFT27-related disorder Pathogenic:1
The IFT27 c.296G>A variant is predicted to result in the amino acid substitution p.Cys99Tyr. This variant has been reported in homozygous individuals with Bardet–Biedl syndrome (Aldahmesh et al. 2014. PubMed ID: 24488770; Table 1, Zhou et al. 2022. PubMed ID: 34888642). Functional analyses in a zebrafish model indicated that this variant is a loss-of-function allele (Aldahmesh et al. 2014. PubMed ID: 24488770). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at